Drugs / Fecal Microbiota Transplant
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02255305 | Jan 2015 → Jan 2020 | Clostridium difficile colitis | Endeavor Health | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fecal Microbiota Transplant | “Fecal Microbiota Transplant” NCT02255305 ↗ |
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02255305 ↗ |
| Action | Restore | “FMT quickly and successfully restores normal intestinal microorganisms of the diseased patient via infusion of a liquid stool preparation from a healthy donor.” NCT02255305 ↗ |
| Modality | Other / unclassified | “fecal microbiota transplantation (FMT)” NCT02255305 ↗ |
| Route | Rectal | “FMT via retention enema” NCT02255305 ↗ |